In conclusion, our study confirms (but also significantly relativizes) the general prognostic relevance of CDX2 loss in colorectal cancer (in univariate analyses) and shows its association with tumour localisation, microsatellite status and certain CRC subtypes. Here, CDX2 is linked to neoplasm.